Historical Valuation
Haoxi Health Technology Ltd (HAO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Haoxi Health Technology Ltd (HAO) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：1.46
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Haoxi Health Technology Ltd (HAO) has a current Price-to-Book (P/B) ratio of 0.17. Compared to its 3-year average P/B ratio of 33.41 , the current P/B ratio is approximately -99.48% higher. Relative to its 5-year average P/B ratio of 33.41, the current P/B ratio is about -99.48% higher. Haoxi Health Technology Ltd (HAO) has a Forward Free Cash Flow (FCF) yield of approximately -39.41%. Compared to its 3-year average FCF yield of -33.44%, the current FCF yield is approximately 17.85% lower. Relative to its 5-year average FCF yield of -33.44% , the current FCF yield is about 17.85% lower.
P/B
Median3y
33.41
Median5y
33.41
FCF Yield
Median3y
-33.44
Median5y
-33.44
Competitors Valuation Multiple
AI Analysis for HAO
The average P/S ratio for HAO competitors is 0.00, providing a benchmark for relative valuation. Haoxi Health Technology Ltd Corp (HAO.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for HAO
1Y
3Y
5Y
Market capitalization of HAO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HAO in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is HAO currently overvalued or undervalued?
Haoxi Health Technology Ltd (HAO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Haoxi Health Technology Ltd (HAO) is between to according to relative valuation methord.
What is Haoxi Health Technology Ltd (HAO) fair value?
HAO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Haoxi Health Technology Ltd (HAO) is between to according to relative valuation methord.
How does HAO's valuation metrics compare to the industry average?
The average P/S ratio for HAO's competitors is 0.00, providing a benchmark for relative valuation. Haoxi Health Technology Ltd Corp (HAO) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Haoxi Health Technology Ltd (HAO) as of Jan 10 2026?
As of Jan 10 2026, Haoxi Health Technology Ltd (HAO) has a P/B ratio of 0.17. This indicates that the market values HAO at 0.17 times its book value.
What is the current FCF Yield for Haoxi Health Technology Ltd (HAO) as of Jan 10 2026?
As of Jan 10 2026, Haoxi Health Technology Ltd (HAO) has a FCF Yield of -39.41%. This means that for every dollar of Haoxi Health Technology Ltd’s market capitalization, the company generates -39.41 cents in free cash flow.
What is the current Forward P/E ratio for Haoxi Health Technology Ltd (HAO) as of Jan 10 2026?
As of Jan 10 2026, Haoxi Health Technology Ltd (HAO) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Haoxi Health Technology Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Haoxi Health Technology Ltd (HAO) as of Jan 10 2026?
As of Jan 10 2026, Haoxi Health Technology Ltd (HAO) has a Forward P/S ratio of 0.00. This means the market is valuing HAO at $0.00 for every dollar of expected revenue over the next 12 months.